Features
Yale’s picks to beat cancer: a pair of aces
An illustrious new chief of medical oncology, a leader for the Yale Cancer Biology Institute boost efforts to develop better drugs for cancer
It has been an eventful December for the advancement of basic and translational cancer research at Yale. On the 13th, Yale University announced that Joseph Schlessinger, Ph.D., a world-renowned scientist with an unparalleled track record of identifying molecular targets for novel anticancer drugs, was named the first director of the University’s new Cancer Biology Institute (CBI), one of five major interdisciplinary research initiatives located on Yale’s West Campus.
Just a week before, Thomas...
Alumna supports doctors who join her on a road less traveled
Medicine offers satisfying careers in both science and patient care, and at the School of Medicine, students and faculty are encouraged to creatively combine these two vocations as physician–scientists. But Marie-Louise T. Johnson, M.D., Ph.D., has forged a career path that is “utterly unique in our field, and an exceptionally lofty model,” says Richard L. Edelson, M.D., chair of the Department of Dermatology, who...
Built from scratch, lungs are a big leap in bioengineering
Laura Niklason, M.D., Ph.D., has spent the past 15 years in the lab developing ways to build new arteries using tissue engineering techniques, but as an anesthesiologist who works in the intensive care unit, she always had another idea rolling around in the back of her head.
...
Medicine@Yale, the bimonthly newsletter of Yale School of Medicine (YSM), chronicles achievements
of YSM in basic and clinical research, medical education, and health care. Read More...
